News | Cardiovascular Education | April 04, 2023

Harding University Introduces New Professional Pathway Tailored to Cardiac Professionals for its Master of Science in Cardiac Function and Interventional Technology

Part-time degree format will provide vital skills for career advancement in cardiac device interventional technologies

Part-time degree format will provide vital skills for career advancement in cardiac device interventional technologies

April 4, 2023 — Harding University has announced it will offer a new degree format for its Master of Science in cardiac function and interventional technology tailored to working professionals in the industry starting this fall. The part-time, hybrid format is called the Master of Science in Cardiac Function and Interventional Technology - Professional Pathway, also known as CFIT-Pro. This intensive 38 credit hour program will be delivered primarily online with one in-person weekend per semester. 

“We are proud to announce the launch of CFIT-Pro, which gives industry professionals the opportunity to further their education and leadership skills,” said Dr. Mike Williams, president of Harding University. “Since launching the traditional program in 2022, we have received many requests for a part-time option, and we are pleased to be able to begin this offering in the fall.” 

CFIT-Pro is an online, part-time program for professionals wishing to advance in their careers in cardiac device companies or with cardiac patient care. The program will help professionals further their knowledge of and training in cardiac function and interventional technology, as well as management and leadership skills. 

“The professional pathway is an ideal program for cardiac professionals who need the hybrid and part-time course schedule,” said Kenneth Turley, Ph.D., FACSM, CFIT director and professor at Harding University's College of Allied Health. “This is an innovative pathway for individuals who want to further their knowledge in cardiac rhythm management and electrophysiology while working simultaneously in the field.” 

Applicants must possess a bachelor’s degree and be currently employed in the fields of cardiac patient care or the cardiac device industry with two or more years of documented experience in their respective fields. 

“Harding has built a program that is tailor-made for the future managers and leaders of cardiac devices and cardiac patient care,” said Mark Sweesy, program consultant for Harding’s CFIT program. “It's exciting to be a part of this successful and innovative program as it expands to provide opportunities for current cardiac device professionals, equipping them technically while developing the management and leadership skills needed to advance their careers.” 

The CFIT-Pro application deadline is July 1, 2023. Visit Harding.edu/CFIT to learn more. 


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now